Comera Life Sciences Stock Book Value Per Share
CMRAWDelisted Stock | USD 0.04 0 5.07% |
Comera Life Sciences fundamentals help investors to digest information that contributes to Comera Life's financial success or failures. It also enables traders to predict the movement of Comera Stock. The fundamental analysis module provides a way to measure Comera Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Comera Life stock.
Comera |
Comera Life Sciences Company Book Value Per Share Analysis
Comera Life's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Comera Life Book Value Per Share | (12.62) X |
Most of Comera Life's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Comera Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Comera Life Sciences is about -12.622 times. This is much higher than that of the Biotechnology sector and 94.92% lower than that of the Health Care industry. The book value per share for all United States stocks is 100.65% higher than that of the company.
Comera Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Comera Life's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Comera Life could also be used in its relative valuation, which is a method of valuing Comera Life by comparing valuation metrics of similar companies.Comera Life is currently under evaluation in book value per share category among its peers.
Comera Fundamentals
Return On Equity | -16.29 | |||
Return On Asset | -1.19 | |||
Operating Margin | (15.82) % | |||
Number Of Shares Shorted | 300 | |||
Revenue | 1 M | |||
EBITDA | (7.55 M) | |||
Net Income | (9.01 M) | |||
Cash And Equivalents | 3.86 M | |||
Cash Per Share | 2.85 X | |||
Total Debt | 775.05 K | |||
Debt To Equity | 0.08 % | |||
Current Ratio | 4.26 X | |||
Book Value Per Share | (12.62) X | |||
Cash Flow From Operations | (6.66 M) | |||
Earnings Per Share | (6.08) X | |||
Number Of Employees | 12 | |||
Beta | 0.41 | |||
Total Asset | 3.73 M | |||
Retained Earnings | (34.9 M) | |||
Working Capital | (2 M) | |||
Z Score | -20.17 | |||
Net Asset | 3.73 M |
About Comera Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Comera Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Comera Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Comera Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Comera Stock
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |